Overview
30-Day Study with 150 Participants
This third double-blind, randomized, placebo, and active comparator-controlled clinical study of 150 subjects with mild to moderate joint discomfort were given 250mg of patented TamaFlex, 1000mg Active Comparator, or a placebo.
By day 5, the TamaFlex group showed a significant reduction in knee discomfort. After 30 days of supplementation with TamaFlex, participants showed a significant reduction in joint discomfort and stiffness and improvement in their physical function and joint comfort.
Length of Study:
30 days
Study Size:
150 participants
Average Age:
60 years
Dose:
250mg TamaFlex daily
Fast-acting relief and improved joint function in just 30 days
uCTX-II
uCTX-II is released into circulation as a result of articular cartilage degeneration.
hsCRP
High-sensitivity C-reactive protein (hsCRP) promotes collagen degeneration via MMP-3 activation.
WOMAC Stiffness
WOMAC is one of the most widely used measures of lower extremity symptoms and function.
Primary Knee Flexion
Knee Flexion demonstrate the angle between the thigh and shin, measured with a goniometer.
30-Second Chair Stand
30SCT measures lower body strength, power, physical function, and number of repetitions.
At the end of 30 days of supplementation, the TamaFlex group showed:
Improved aerobic capacity and endurance of subjects with knee discomfort.
Measured by absolute distance walked by subjects in a six-minute walk test.
Increased lower body strength, power, and physical function.
Significant increase in mean time covered during the stair climb test.
Improved ability to perform a chair-stand test.
This is seen as an increase in the number of repetitions in 30 seconds.
More TamaFlex Studies
More TamaFlex Clinical Studies
Explore our other clinical studies to see how TamaFlex consistently delivers remarkable improvements in joint health.
Clinical Study 1
90-Day Study in healthy participants showed significant reduction in joint pain and improved mobility.
Clinical Study 2
2-Month Study in participants with mild to moderate joint pain, showed rapid and sustained joint health benefits.
More TamaFlex Studies
More TamaFlex Clinical Studies
Explore our other clinical studies to see how TamaFlex consistently delivers remarkable improvements in joint health.
Clinical Study 1
90-Day Study in healthy participants showed significant reduction in joint pain and improved mobility.
Clinical Study 2
2-Month Study in participants with mild to moderate joint pain, showed rapid and sustained joint health benefits.
References:
Prasad N., Vinay V., and Srivastava A. Efficacy of a Proprietary Combination of Tamarindus indica Seeds and Curcuma longa Rhizome Extracts in Osteoarthritis: A Clinical Investigation. Food & Nutrition Research, vol. 67, 2023 June 20, doi: 10.29219/fnr.v67.9268.
Take Your Brand to the NXT Level with TamaFlex!
Contact Us to Explore TamaFlex’s Benefits!